{
  "id": 4779,
  "url": "https://nnemf.org/research/4779-low-frequency-electromagnetic-field-conditioning-protects-against-i",
  "title": "Low Frequency Electromagnetic Field Conditioning Protects against I/R Injury and Contractile Dysfunction in the Isolated Rat Heart.",
  "authors": [
    "Dariusz Bialy",
    "Magdalena Wawrzynska",
    "Iwona Bil-Lula",
    "Anna Krzywonos-Zawadzka",
    "Mieczyslaw Wozniak",
    "Virgilio J J Cadete",
    "Grzegorz Sawicki"
  ],
  "journal": "BioMed research international",
  "year": "2015",
  "doi": "10.1155/2015/396593",
  "pmid": "25961016",
  "abstract": "Low frequency electromagnetic field (LF-EMF) decreases the formation of reactive oxygen species, which are key mediators of ischemia/reperfusion (I/R) injury. Therefore, we hypothesized that the LF-EMF protects contractility of hearts subjected to I/R injury. Isolated rat hearts were subjected to 20 min of global no-flow ischemia, followed by 30 min reperfusion, in the presence or absence of LF-EMF. Coronary flow, heart rate, left ventricular developed pressure (LVDP), and rate pressure product (RPP) were determined for evaluation of heart mechanical function. The activity of cardiac matrix metalloproteinase-2 (MMP-2) and the contents of coronary effluent troponin I (TnI) and interleukin-6 (IL-6) were measured as markers of heart injury. LF-EMF prevented decreased RPP in I/R hearts, while having no effect on coronary flow. In addition, hearts subjected to I/R exhibited significantly increased LVDP when subjected to LF-EMF. Although TnI and IL-6 levels were increased in I/R hearts, their levels returned to baseline aerobic levels in I/R hearts subjected to LF-EMF. The reduced activity of MMP-2 in I/R hearts was reversed in hearts subjected to LF-EMF. The data presented here indicate that acute exposure to LF-EMF protects mechanical function of I/R hearts and reduces I/R injury.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "animal",
    "studyTypeLabel": "Animal study",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Isolated rat hearts (ex vivo)",
    "sampleSize": "—",
    "exposure": "ELF · acute; during 20 min ischemia and 30 min reperfusion (isolated rat heart I/R protocol)",
    "confidencePct": "78",
    "peerReviewed": "yes",
    "mainFindings": "In isolated rat hearts subjected to ischemia/reperfusion, LF-EMF exposure prevented a decrease in rate pressure product and increased LVDP, with no effect on coronary flow. Elevated TnI and IL-6 in I/R hearts returned to baseline levels with LF-EMF, and reduced MMP-2 activity in I/R hearts was reversed by LF-EMF.",
    "outcomes": [
      "Heart mechanical function (coronary flow",
      "heart rate",
      "left ventricular developed pressure (LVDP)",
      "rate pressure product (RPP))",
      "Markers of heart injury (troponin I (TnI)",
      "interleukin-6 (IL-6))",
      "Cardiac matrix metalloproteinase-2 (MMP-2) activity"
    ],
    "limitations": [
      "Frequency and field strength/dose parameters of LF-EMF not reported in the abstract",
      "Ex vivo isolated rat heart model",
      "generalizability to in vivo or humans not addressed in the abstract",
      "Sample size not provided in the abstract"
    ],
    "keywords": [
      "low frequency electromagnetic field",
      "LF-EMF",
      "ELF",
      "ischemia/reperfusion",
      "isolated rat heart",
      "contractile dysfunction",
      "reactive oxygen species",
      "troponin I",
      "interleukin-6",
      "MMP-2",
      "rate pressure product",
      "left ventricular developed pressure"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"animal\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": null,\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": \"acute; during 20 min ischemia and 30 min reperfusion (isolated rat heart I/R protocol)\"\n  },\n  \"population\": \"Isolated rat hearts (ex vivo)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Heart mechanical function (coronary flow, heart rate, left ventricular developed pressure (LVDP), rate pressure product (RPP))\",\n    \"Markers of heart injury (troponin I (TnI), interleukin-6 (IL-6))\",\n    \"Cardiac matrix metalloproteinase-2 (MMP-2) activity\"\n  ],\n  \"main_findings\": \"In isolated rat hearts subjected to ischemia/reperfusion, LF-EMF exposure prevented a decrease in rate pressure product and increased LVDP, with no effect on coronary flow. Elevated TnI and IL-6 in I/R hearts returned to baseline levels with LF-EMF, and reduced MMP-2 activity in I/R hearts was reversed by LF-EMF.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"Frequency and field strength/dose parameters of LF-EMF not reported in the abstract\",\n    \"Ex vivo isolated rat heart model; generalizability to in vivo or humans not addressed in the abstract\",\n    \"Sample size not provided in the abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.78,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"low frequency electromagnetic field\",\n    \"LF-EMF\",\n    \"ELF\",\n    \"ischemia/reperfusion\",\n    \"isolated rat heart\",\n    \"contractile dysfunction\",\n    \"reactive oxygen species\",\n    \"troponin I\",\n    \"interleukin-6\",\n    \"MMP-2\",\n    \"rate pressure product\",\n    \"left ventricular developed pressure\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/25961016/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=4779",
  "updated": "2026-02-14 08:04:38"
}